SHR # 2233 :: SFH: New Anti-obesity Drug Reduces Hepatic and Intramuscular Fat ::
22 ago 2018 ·
59 min. 48 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
SHR # 2233 :: SFH: New Anti-obesity Drug Reduces Hepatic and Intramuscular Fat :: Dr. Jeff Golini, PhD - You heard it here first. Scientist in Australia went searching for...
mostra di più
SHR # 2233 :: SFH: New Anti-obesity Drug Reduces Hepatic and Intramuscular Fat :: Dr. Jeff Golini, PhD - You heard it here first. Scientist in Australia went searching for an enzyme responsible for the onset of Type 2 #Diabetes and found a way to reverse the infiltration of fat into liver and muscle tissue. They are now embarking on launching a new #antiobesity drug instead of a Type 2 Diabetes drug. This drug could also help the millions of people who suffer from #NAFLD. PLUS Why Carl tapes his mouth shut at night while he's sleeping. It all started when he was in Los Angeles at the Quest Think Tank. PLUS Metagenics is a 30 year old nutraceutical company that spends over $7 million a year on R and D. ::
mostra meno
Informazioni
Autore | Super Human Radio |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company